Updated Centers for Disease Control and Prevention Guidelines on Opioid Prescribing: What Should Surgeons Know?
Otolaryngol Head Neck Surg
; 169(2): 441-443, 2023 08.
Article
em En
| MEDLINE
| ID: mdl-36939524
ABSTRACT
The Centers for Disease Control and Prevention (CDC) recently published a 2022 guideline on opioid prescribing for acute, subacute, and chronic pain. This information is relevant to surgeons because many patients receive their first opioid prescription after surgery. When prescribing opioids, surgeons walk the line between benefit and harm. Many of the CDC recommendations mirror the AAO-HNS Clinical Practice Guideline Opioid Prescribing for Analgesia After Common Otolaryngology Operations. For example, opioids are not recommended as first-line therapy for acute pain from otolaryngology-head, and neck surgery procedures. New insights include safeguards and strategies to mitigate the risk of complications in patients with chronic pain undergoing surgical procedures. Consultation with a pain specialist should be considered for patients transitioning from acute to chronic pain, cognizant of the risks of abrupt discontinuation of opioids in patients with opioid use disorder. This article summarizes key considerations for providing individualized, evidence-based perioperative pain management.
Palavras-chave
CDC; Centers for Disease Control and Prevention; NSAID; acetaminophen; analgesia; bleeding; chronic pain; guideline; health disparities; health equity; hydrocodone; ibuprofen; nonsteroidal anti-inflammatory drug; opiate; opioid; opioid use disorder; otolaryngology; pain; pain management; persistent opioid use; postoperative; surgery; tonsillectomy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Dor Crônica
/
Cirurgiões
Tipo de estudo:
Guideline
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article